These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 9916917)

  • 1. Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions.
    Van Der Voorn P; Tekstra J; Beelen RH; Tensen CP; Van Der Valk P; De Groot CJ
    Am J Pathol; 1999 Jan; 154(1):45-51. PubMed ID: 9916917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein.
    Calderon TM; Eugenin EA; Lopez L; Kumar SS; Hesselgesser J; Raine CS; Berman JW
    J Neuroimmunol; 2006 Aug; 177(1-2):27-39. PubMed ID: 16782208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study.
    McManus C; Berman JW; Brett FM; Staunton H; Farrell M; Brosnan CF
    J Neuroimmunol; 1998 Jun; 86(1):20-9. PubMed ID: 9655469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue.
    Simpson J; Rezaie P; Newcombe J; Cuzner ML; Male D; Woodroofe MN
    J Neuroimmunol; 2000 Aug; 108(1-2):192-200. PubMed ID: 10900353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible nitric oxide synthase and nitrotyrosine are found in monocytes/macrophages and/or astrocytes in acute, but not in chronic, multiple sclerosis.
    Oleszak EL; Zaczynska E; Bhattacharjee M; Butunoi C; Legido A; Katsetos CD
    Clin Diagn Lab Immunol; 1998 Jul; 5(4):438-45. PubMed ID: 9665945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis.
    Tanuma N; Sakuma H; Sasaki A; Matsumoto Y
    Acta Neuropathol; 2006 Aug; 112(2):195-204. PubMed ID: 16733654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions.
    Hulshof S; Montagne L; De Groot CJ; Van Der Valk P
    Glia; 2002 Apr; 38(1):24-35. PubMed ID: 11921201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures.
    De Groot CJ; Montagne L; Barten AD; Sminia P; Van Der Valk P
    J Neuropathol Exp Neurol; 1999 Feb; 58(2):174-87. PubMed ID: 10029100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions.
    Simpson JE; Newcombe J; Cuzner ML; Woodroofe MN
    J Neuroimmunol; 1998 Apr; 84(2):238-49. PubMed ID: 9628469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions.
    De Groot CJ; Ruuls SR; Theeuwes JW; Dijkstra CD; Van der Valk P
    J Neuropathol Exp Neurol; 1997 Jan; 56(1):10-20. PubMed ID: 8990125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine triphosphate-binding cassette transporters mediate chemokine (C-C motif) ligand 2 secretion from reactive astrocytes: relevance to multiple sclerosis pathogenesis.
    Kooij G; Mizee MR; van Horssen J; Reijerkerk A; Witte ME; Drexhage JA; van der Pol SM; van Het Hof B; Scheffer G; Scheper R; Dijkstra CD; van der Valk P; de Vries HE
    Brain; 2011 Feb; 134(Pt 2):555-70. PubMed ID: 21183485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid precursor protein (APP) expression in multiple sclerosis lesions.
    Gehrmann J; Banati RB; Cuzner ML; Kreutzberg GW; Newcombe J
    Glia; 1995 Oct; 15(2):141-51. PubMed ID: 8567065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nogo-A and nogo receptor expression in demyelinating lesions of multiple sclerosis.
    Satoh J; Onoue H; Arima K; Yamamura T
    J Neuropathol Exp Neurol; 2005 Feb; 64(2):129-38. PubMed ID: 15751227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions.
    Cossins JA; Clements JM; Ford J; Miller KM; Pigott R; Vos W; Van der Valk P; De Groot CJ
    Acta Neuropathol; 1997 Dec; 94(6):590-8. PubMed ID: 9444361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions.
    Boven LA; Montagne L; Nottet HS; De Groot CJ
    Clin Exp Immunol; 2000 Nov; 122(2):257-63. PubMed ID: 11091283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate.
    Brück W; Popescu B; Lucchinetti CF; Markovic-Plese S; Gold R; Thal DR; Metz I
    Ann Neurol; 2012 Sep; 72(3):385-94. PubMed ID: 23034911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis.
    van Horssen J; van der Pol S; Nijland P; Amor S; Perron H
    Mult Scler Relat Disord; 2016 Jul; 8():11-8. PubMed ID: 27456869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase-19 is highly expressed in active multiple sclerosis lesions.
    van Horssen J; Vos CM; Admiraal L; van Haastert ES; Montagne L; van der Valk P; de Vries HE
    Neuropathol Appl Neurobiol; 2006 Dec; 32(6):585-93. PubMed ID: 17083473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions.
    van Horssen J; Drexhage JA; Flor T; Gerritsen W; van der Valk P; de Vries HE
    Free Radic Biol Med; 2010 Nov; 49(8):1283-9. PubMed ID: 20673799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of monocyte chemotactic protein-1 and CC chemokine receptor 2 in the central nervous system is closely associated with relapse of autoimmune encephalomyelitis in Lewis rats.
    Jee Y; Yoon WK; Okura Y; Tanuma N; Matsumoto Y
    J Neuroimmunol; 2002 Jul; 128(1-2):49-57. PubMed ID: 12098510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.